HealthDay News — Mobile telephone text messaging may be a promising new way to improve adherence to medications for chronic diseases, according to research published in JAMA Internal Medicine.
Jay Thakkar, MD, of the University of Sydney, and colleagues performed a meta-analysis of data from 16 randomized clinical trials evaluating the effects of a mobile telephone text message intervention to promote adherence to medication in adults with chronic disease.1
TRENDING ON CPA: ACA Supports Proposed Guideline for Prescribing Opioids to Patients With Chronic Pain
The researchers found that in a pooled analysis of data from 2742 patients (median age, 39 years), electronic reminders sent via text messaging significantly improved medication adherence (odds ratio, 2.11; P < 0.001). Among the studies, 5 used personalization, 8 used 2-way communication, and 8 used a daily text message frequency.
The effect was not sensitive to these text message characteristics or to study characteristics such as intervention duration or type of disease.
After adjusting for publication bias, the point estimate was smaller but still positive for an intervention effect (odds ratio, 1.68; P < 0.05).
“Text messaging has potential as a widespread, low-cost technology but will need more development and rigorous testing to determine if it has real, enduring, and patient-important benefits that are worth the investment,” write the authors of an accompanying editorial.2
One author disclosed financial ties to pharmaceutical companies.
1. Thakkar J, Kurup R, Laba T et al. Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease. JAMA Intern Med. 2016. doi:10.1001/jamainternmed.2015.7667.
2. Nieuwlaat R, Mistry N, Haynes R. Mobile Text Messaging and Adherence of Patients to Medication Prescriptions. JAMA Intern Med. 2016. doi:10.1001/jamainternmed.2015.7853.